How Pharmacy Businesses Are Valued in Ohio
The standard valuation methodology for a pharmacy uses revenue/prescription count multiple, with typical transaction multiples of 0.2-0.5x revenue or $3-8 per Rx. In Ohio, local market conditions—including the Columbus, Cleveland, Cincinnati metropolitan areas—influence where a specific business falls within that range.
Independent pharmacies are valued on revenue multiples or a per-prescription basis, with adjustments for PBM reimbursement mix, specialty drug percentage, and 340B participation. Specialty and compounding pharmacies command significant premiums over traditional retail.
The Ohio Business Environment
Ohio has three major metro areas with distinct economies: Columbus (insurance, tech, education), Cleveland (healthcare, manufacturing), and Cincinnati (consumer products, healthcare). The state has no corporate income tax on pass-through entities.
Ohio's three diverse metros and no corporate income tax on pass-throughs make it an active lower-middle-market M&A state.
Ohio's state income tax should be factored into after-tax proceeds analysis when evaluating sale offers.
Key Value Drivers for Pharmacy Businesses in Ohio
- Prescription volume and growth
- Specialty/compounding revenue
- 340B program participation
- PBM contract terms
Ohio Market Considerations
The major metro areas in Ohio—Columbus, Cleveland, Cincinnati, Dayton—each have distinct competitive dynamics that affect pharmacy valuations. Businesses in larger metros typically command higher multiples due to larger addressable markets and deeper buyer pools, while rural Ohio businesses may trade at a discount but often have less competition and stronger community ties.
With 990,000+ small businesses statewide and a population of 11.8M, Ohio represents a major market for pharmacy transactions. Buyers evaluating pharmacy businesses in Ohio will factor in regional competition, labor market conditions, and local regulatory requirements.